TCL Archive As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study November 21, 2014
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive In Brief: Des Exposed Women Face New Risk: Unfavorable Pregnancies; Hutchinson Labor Election Set March 21, 1980